一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>251303-04-5

251303-04-5

中文名稱(chēng) ERTIPROTAFIB
英文名稱(chēng) Ertiprotafib
CAS 251303-04-5
分子式 C31H27BrO3S
分子量 559.52
MOL 文件 251303-04-5.mol
更新日期 2024/07/24 18:26:22
251303-04-5 結(jié)構(gòu)式 251303-04-5 結(jié)構(gòu)式

基本信息

中文別名
化合物 T15243
英文別名
PTP 112
Ertiprotafib
Benzenepropanoic acid, a-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-,(aR)-
Benzenepropanoic acid, α-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (αR)-
所屬類(lèi)別
生物化工:抑制劑

物理化學(xué)性質(zhì)

沸點(diǎn)690.7±55.0 °C(Predicted)
密度1.376±0.06 g/cm3(Predicted)
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度溶于二甲基亞砜
酸度系數(shù)(pKa)3.21±0.10(Predicted)
形態(tài)Solid
顏色Light yellow to yellow
化合物 T15243價(jià)格(試劑級(jí))
報(bào)價(jià)日期產(chǎn)品編號(hào)產(chǎn)品名稱(chēng)CAS號(hào)包裝價(jià)格
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-51 mg1590元
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-55 mg3500元
2026/06/05HY-19383化合物 T15243
Ertiprotafib
251303-04-510 mM * 1 mLin DMSO4308元

常見(jiàn)問(wèn)題列表

生物活性
Ertiprotafib 是 PTP1B, IKK-β 的抑制劑,其 IC50 值分別是 1.6 μM,400 nM,同時(shí)也是PPARα/PPARβ 的激動(dòng)劑,其 EC50 值為 ~1 μM。
靶點(diǎn)

PTP1B

1.6 μM (IC 50 )

IKK-β

400 nM (IC 50 )

PPARα

~1 μM (EC 50 )

PPARβ

~1 μM (EC 50 )

體外研究

Ertiprotafib is a potent inhibitor of IKK-β, with an IC 50 value of 400±40 nM, which is much lower than that required for the half-maximal inhibition of the p-nitrophenyl phosphatase activity of PTP1B. The reported IC 50 value of Ertiprotafib against PTP1B ranges from 1.6 to 29 μM depending on the assay conditions. Ertiprotafib is at least a dual PPARα and PPARβ agonist with EC 50 values for transactivation of 1 μM. Such activities readily explain the observations with suprapharmacologic doses of these.

體內(nèi)研究

As seen with treatment of ob/ob mice, both Ertiprotafib and compound 3 seem to significantly improve glucose metabolism in rats. At 25 mg/kg/day, these compounds decrease both fasting blood glucose and insulin levels compared with vehicle treated rats. Furthermore, both Ertiprotafib and compound 3 increase glucose disposal after an oral challenge. It is noteworthy that lipid levels are also reduced in treated animals. Both triglyceride and free fatty acid levels are substantially reduced in rats treated with 25 mg/kg/day of either compound. To summarize, both Ertiprotafib and compound 3 seem to be robust agents in improving glucose utilization in fa/fa rats while also decreasing lipid levels in these animals. Decreased lipid levels may be unexpected for a pure PTP1b inhibitor. It is more telling, as mentioned above, that rats treated with suprapharmacologic doses of Ertiprotafib show signs of PPAR family activation.

"251303-04-5" 相關(guān)產(chǎn)品信息
251303-04-5
黄骅市| 敦化市| 绥滨县| 怀宁县| 太康县| 洞口县| 安义县| 治多县| 淮南市| 灵山县| 台东县| 南昌县| 竹山县| 威远县| 台湾省| 繁昌县| 临安市| 曲沃县| 陵川县| 莱州市| 泰兴市| 牙克石市| 瓮安县| 婺源县| 西丰县| 遂昌县| 彩票| 疏勒县| 仁布县| 祁东县| 凤城市| 自贡市| 广汉市| 观塘区| 布拖县| 聊城市| 富顺县| 关岭| 卢氏县| 翁牛特旗| 上思县|